Aarti Pharmalabs Limited (BOM:543748)

Aarti Pharmalabs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	96.16	67.34	236.35	121.21	832.73
Short-Term Investments	-	-	491.23	706.82	-	-
Trading Asset Securities	-	-	-	-	509.9	-
Cash & Short-Term Investments	96.16	96.16	558.57	943.17	631.11	832.73
Cash Growth	-82.89%	-82.78%	-40.78%	49.45%	-24.21%	33209.36%
Accounts Receivable	-	5,833	5,754	5,193	4,501	3,767
Other Receivables	-	99.35	93.57	108.61	53.71	65.42
Receivables	-	5,938	5,858	5,315	4,567	3,893
Inventory	-	6,403	5,876	6,429	6,020	4,755
Prepaid Expenses	-	-	63.44	61.48	23.25	41.96
Other Current Assets	-	1,536	866.12	708.61	388.04	758.89
Total Current Assets	-	13,973	13,222	13,456	11,630	10,281
Property, Plant & Equipment	-	17,067	14,107	10,932	9,861	9,453
Long-Term Investments	-	1,938	292.41	367.8	355.25	322.26
Goodwill	-	-	17.81	17.81	17.81	17.81
Other Intangible Assets	-	1,239	984.4	752.74	398.5	223.65
Other Long-Term Assets	-	522.4	367.74	235.89	119.32	100.67
Total Assets	-	34,817	29,064	25,821	22,440	20,399

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	3,345	2,778	3,783	3,395	2,146
Accrued Expenses	-	112.21	509.18	373.34	198.41	87.83
Short-Term Debt	-	4,998	2,928	2,641	2,142	3,377
Current Portion of Long-Term Debt	-	-	-	-	-	3.42
Current Portion of Leases	-	165.51	50.94	44.91	4.45	12.44
Current Income Taxes Payable	-	-	11.45	-	35.15	75
Other Current Liabilities	-	754.36	292.66	101.83	231.68	104.8
Total Current Liabilities	-	9,376	6,570	6,944	6,006	5,807
Long-Term Debt	-	2,252	1,113	0.39	1.84	5.55
Long-Term Leases	-	521.76	116.69	166.59	5.32	15.32
Pension & Post-Retirement Benefits	-	-	8.31	6.18	5.47	-
Long-Term Deferred Tax Liabilities	-	1,343	1,284	1,079	788.38	706.7
Other Long-Term Liabilities	-	78.52	72.87	54.41	48.14	-
Total Liabilities	-	13,571	9,165	8,251	6,855	6,534

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	453.29	453.17	453.13	453.13	2.5
Additional Paid-In Capital	-	-	4,408	4,403	4,403	4,403
Retained Earnings	-	-	14,131	11,734	9,746	8,006
Comprehensive Income & Other	-	20,793	906.85	979.81	982.06	1,453
Shareholders' Equity	21,246	21,246	19,899	17,570	15,585	13,865
Total Liabilities & Equity	-	34,817	29,064	25,821	22,440	20,399

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	7,937	7,937	4,208	2,853	2,153	3,414
Net Cash (Debt)	-7,841	-7,841	-3,650	-1,909	-1,522	-2,581
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-86.36	-86.40	-40.24	-21.07	-16.79	-28.48
Filing Date Shares Outstanding	90.65	90.69	90.63	90.63	90.63	90.63
Total Common Shares Outstanding	90.65	90.69	90.63	90.63	90.63	90.63
Working Capital	-	4,597	6,651	6,513	5,624	4,475
Book Value Per Share	234.27	234.27	219.55	193.88	171.97	152.99
Tangible Book Value	20,007	20,007	18,897	16,800	15,169	13,623
Tangible Book Value Per Share	220.61	220.61	208.49	185.38	167.38	150.32
Land	-	-	841.46	779.38	669.32	641.01
Buildings	-	-	1,848	1,668	1,568	1,202
Machinery	-	-	14,218	12,789	11,610	9,941
Construction In Progress	-	-	3,066	784.97	622.04	1,652

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error